<SEC-DOCUMENT>0001628280-25-024067.txt : 20250509
<SEC-HEADER>0001628280-25-024067.hdr.sgml : 20250509
<ACCEPTANCE-DATETIME>20250509082353
ACCESSION NUMBER:		0001628280-25-024067
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250509
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250509
DATE AS OF CHANGE:		20250509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vir Biotechnology, Inc.
		CENTRAL INDEX KEY:			0001706431
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				812730369
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39083
		FILM NUMBER:		25928483

	BUSINESS ADDRESS:	
		STREET 1:		1800 OWENS STREET
		STREET 2:		SUITE 900
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158
		BUSINESS PHONE:		415-906-4324

	MAIL ADDRESS:	
		STREET 1:		1800 OWENS STREET
		STREET 2:		SUITE 900
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>vir-20250509.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:6a9a721f-3de6-4a3c-971f-5dbb294c6c9c,g:d8e09db2-1647-4a04-ba40-d5b7d57fbe81,d:ae8a0af24169483f87b57e02bf96940b-->
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>vir-20250509</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-23">0001706431</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="vir-20250509.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001706431</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-09</xbrli:startDate><xbrli:endDate>2025-05-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001706431</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNAS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-09</xbrli:startDate><xbrli:endDate>2025-05-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iae8a0af24169483f87b57e02bf96940b_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________________________________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________________________________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">May&#160;9, 2025</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________________________________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Vir Biotechnology, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Exact name of Registrant as Specified in Its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________________________________________</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-39083</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">81-2730369</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(State or Other Jurisdiction <br/>of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(IRS Employer <br/>Identification No.)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">1800 Owens Street</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 900</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">San Francisco</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">California</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">94158</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Zip Code)</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">415</ix:nonNumeric>)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">906-4324</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________________________________________</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-17">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:38.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.660%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trading <br/>Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common stock, $0.0001 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">VIR</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#212529;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-21">o</ix:nonNumeric></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#212529;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iae8a0af24169483f87b57e02bf96940b_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01 Other Events</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 9, 2025, Vir Biotechnology, Inc. (the Company) issued a press release announcing 24-week post-end of treatment data from Part B of its ongoing MARCH Phase 2 clinical study evaluating tobevibart, an investigational broadly neutralizing monoclonal antibody targeting the hepatitis B surface antigen, and elebsiran, an investigational hepatitis B virus-targeting small interfering ribonucleic acid, with or without pegylated interferon alpha, for the treatment of participants living with chronic hepatitis B. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not secured a development partner for the chronic hepatitis B program to date, and will not allocate additional resources beyond completing the ongoing Phase 2 study while minimizing cost. As stated in the press release, the Company will streamline the final stages of the MARCH Phase 2 study. This decision aligns with the Company's previously announced prioritization of its ECLIPSE Phase 3 registrational program for chronic hepatitis delta and its dual-masked T-cell engager oncology programs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The detailed data were presented today at the European Association for the Study of the Liver (EASL) Congress 2025 in Amsterdam (the Netherlands).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.</span></div><div id="iae8a0af24169483f87b57e02bf96940b_86"></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) Exhibits</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.294%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="ex991pressrelease_marchdata.htm">Press Release of the Company, dated May 9, 2025</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iae8a0af24169483f87b57e02bf96940b_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:53.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIR BIOTECHNOLOGY, INC.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 9, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Marianne De Backer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marianne De Backer, M.Sc., Ph.D., MBA<br/>Chief Executive Officer</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991pressrelease_marchdata.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i2cc0d18164a04722a6667233779e02a5_78"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div></div><div style="text-align:justify"><img alt="imagea.jpg" src="imagea.jpg" style="height:57px;margin-bottom:5pt;vertical-align:text-bottom;width:246px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:14.2pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.09pt">HBsAg loss 24 weeks post-end of treatment achieved in 17% and 21% of participants with low baseline HBsAg receiving tobevibart + elebsiran without or with PEG-IFN&#945;, respectively </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:14.2pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.09pt">As previously announced, Phase 3 development in chronic hepatitis B to occur only with a global development and commercialization partner, which has not been secured</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:14.2pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.09pt">Vir Biotechnology to streamline the final stages of MARCH Phase 2 study to ensure continued participant benefit and safety, while applying continued financial stewardship  </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:14.2pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.09pt">The Company reiterates cash runway guidance into mid-2027, based on the current operating plan</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:14.2pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8211;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:8.09pt">The Company remains committed to its chronic hepatitis delta program, based on the transformational potential of tobevibart + elebsiran to achieve complete hepatitis delta viral suppression in a majority of patients</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SAN FRANCISCO, May 9, 2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#8211; Vir Biotechnology, Inc. (Nasdaq&#58; VIR) today announced 24-week post-end of treatment data from Part B of the ongoing MARCH Phase 2 clinical study evaluating tobevibart and elebsiran without or with pegylated interferon alpha (PEG-IFN&#945;) in participants with chronic hepatitis B (CHB). The study-defined primary endpoint, proportion of participants with undetectable hepatitis B surface antigen (HBsAg) at 24 weeks post-end of treatment, was achieved by 17% (3&#47;18) and 21% (3&#47;14) of participants with baseline HBsAg&#60;1,000 IU&#47;mL receiving tobevibart and elebsiran without or with PEG-IFN&#945;, respectively. The detailed data were presented today at the European Association for the Study of the Liver (EASL) congress in Amsterdam (The Netherlands).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CHB is a long-lasting, inflammatory liver disease caused by the hepatitis B virus (HBV).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The World Health Organization estimates that 254 million people live with CHB, and an estimated 1.1 million yearly deaths are associated with the disease.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Complications from CHB may include liver cirrhosis, liver failure and liver cancer.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Although CHB can be treated, there is currently no cure.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Participants in the trial received tobevibart and elebsiran without or with PEG-IFN&#945;. Tobevibart was administered at 300 mg every 4 weeks&#59; elebsiran, at 200 mg every 4 weeks&#59; and PEG-IFN&#945;, for patients receiving it, at 180 &#181;g weekly. Participants with HBsAg loss (seroclearance) after 48 weeks of treatment who met eligibility criteria discontinued both NRTI (nucleos(t)ide reverse transcriptase inhibitor) as well as tobevibart and elebsiran without or with PEG-IFN&#945; treatment. The current analysis includes data from participants in the trial who have reached Week 24 post-end of treatment&#58; 51 participants receiving tobevibart and elebsiran without PEG-IFN&#945; and 32 receiving tobevibart and elebsiran with PEG-IFN&#945;. An additional 18 participants receiving tobevibart and elebsiran with PEG-IFN&#945; are currently advancing through the trial. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Study-defined primary efficacy endpoint &#8211;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The study-defined primary efficacy endpoint is proportion of participants with HBsAg seroclearance (defined as undetectable HBsAg) at 24 weeks post-end of treatment. Tobevibart and elebsiran without or with PEG-IFN&#945; resulted in HBsAg loss 24 weeks post-end of treatment in 17% (3&#47;18) and 21% (3&#47;14) of participants with baseline HBsAg&#60;1,000 IU&#47;mL, respectively. These proportions were 8% (4&#47;51) and 16% (5&#47;32) for tobevibart and elebsiran without or with PEG-IFN&#945;, respectively, in all participants.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Functional cure &#8211;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Functional cure is defined as sustained undetectable HBsAg and HBV DNA below the lower limit of quantification (0.05 IU&#47;mL) at 24 weeks post-end of treatment after discontinuing NRTIs. Tobevibart and elebsiran without or with PEG-IFN&#945; resulted in functional cure in 11% (2&#47;18) and 15% (2&#47;13) of participants with HBsAg&#60;1000 IU&#47;mL, respectively. These proportions were 4% (2&#47;51) and 10% (3&#47;30) for the combinations without or with PEG-IFN&#945;, respectively, in all participants. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Modified functional cure (allowing viral blips) &#8211;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> An exploratory modified functional cure, allowing transient viremia (viral blips) defined as HBV RNA or HBsAg equal or above the lower limit of quantification for &#8804;35 days, was also evaluated. Tobevibart and elebsiran without or with PEG-IFN&#945; resulted in 24 weeks post-end of treatment modified functional cure rates of 11% (2&#47;18) and 23% (3&#47;13) in participants with HBsAg&#60;1000 IU&#47;mL, respectively. These proportions were 6% (3&#47;51) and 13% (4&#47;30) for the combinations without or with PEG-IFN&#945;, respectively, in all participants. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The safety and tolerability profile of tobevibart and elebsiran are consistent with prior studies. The data show that the combination is well tolerated, with no new safety concerns and generally only mild or moderate treatment emergent adverse events being reported throughout the study. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#34;The MARCH data demonstrate that combinations of tobevibart and elebsiran can achieve and maintain HBsAg loss in a subset of participants with low baseline HBsAg levels,&#8221; said Mark Eisner, MD., MPH, Chief Medical Officer, Vir Biotechnology. &#8220;These findings provide important insights into the challenges of achieving functional cure in chronic hepatitis B and will inform future development efforts in the field.&#8221; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As previously communicated, Phase 3 development of combinations of tobevibart and elebsiran in CHB will not move forward without a global development and commercialization partner, which has not been secured. The Company plans to streamline the final stages of the MARCH Phase 2 program to ensure continued participant benefit and safety, while applying continued financial stewardship. Cash runway guidance into mid-2027 remains unchanged, based on the current operating plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Vir Biotechnology is fully committed to the continued development of tobevibart and elebsiran in chronic hepatitis delta, based on the transformational potential of the first-of-its-kind investigational combination to achieve complete suppression of the hepatitis delta virus, as shown by compelling positive efficacy and safety data from the Phase 2 SOLSTICE clinical trial. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Tobevibart and Elebsiran </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Tobevibart is an investigational broadly neutralizing monoclonal antibody targeting the hepatitis B surface antigen (HBsAg). It is designed to inhibit the entry of hepatitis B and hepatitis delta viruses into hepatocytes and to reduce the level of circulating viral and subviral particles in the blood. Tobevibart was identified using Vir Biotechnology&#8217;s proprietary monoclonal antibody discovery platform. The Fc domain has been engineered to increase immune engagement and clearance of HBsAg immune complexes and incorporates Xencor&#8217;s Xtend&#8482; technology to extend half-life. Tobevibart is administered subcutaneously, and it is currently in clinical development for the treatment of patients with chronic hepatitis delta.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Elebsiran is an investigational hepatitis B virus-targeting small interfering ribonucleic acid (siRNA) discovered by Alnylam Pharmaceuticals, Inc. It is designed to degrade hepatitis B virus RNA transcripts and limit the production of hepatitis B surface antigen. Current data indicates that it has the potential to have direct antiviral activity against hepatitis B virus and hepatitis delta virus. Elebsiran is administered subcutaneously, and it is currently in clinical development for the treatment of patients with chronic hepatitis delta. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Vir Biotechnology, Inc. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Vir Biotechnology, Inc., is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology routinely posts information that may be important to investors on its website.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">References&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CDC </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Hepatitis B Basics &#124; Hepatitis B &#124; CDC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, accessed April 2025.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">2&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">World Health Organization. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Global Hepatitis Report 2024&#58; Action for Access in Low- and Middle-income Countries</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. World Health Organization&#59; 2024.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">3&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NIH National Institute of Diabetes and Digestive and Kidney Diseases </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Hepatitis B - NIDDK (nih.gov)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, accessed April 2025.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward-Looking Statements </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as &#8220;should,&#8221; &#8220;could,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;aim,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;promising&#8221; and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements contained in this press release include, but are not limited to, statements regarding&#58; the therapeutic potential of the combination of tobevibart and elebsiran to treat chronic hepatitis B and chronic hepatitis delta&#59; Vir Biotechnology&#8217;s commitment to the continued development of the combination of tobevibart and elebsiran in chronic hepatitis delta and the transformational potential of the combination to achieve complete hepatitis delta viral suppression in a majority of patients&#59; Vir Biotechnology&#8217;s anticipated cash runway&#59; Vir Biotechnology&#8217;s strategy and plans&#59; and any assumptions underlying any of the foregoing. Many factors may cause differences between current expectations and actual results, including, without limitation&#58; unexpected safety or efficacy data or results observed during clinical studies or in data readouts, including the occurrence of adverse safety events&#59; risks of unexpected costs, delays or other unexpected hurdles&#59; challenges in accessing manufacturing capacity&#59; clinical site activation rates or clinical enrollment rates that are lower than expected&#59; the timing and outcome of Vir Biotechnology&#8217;s planned interactions with regulatory authorities, as well as general difficulties in obtaining any necessary regulatory approvals&#59; successful development and&#47;or commercialization of alternative product candidates by Vir Biotechnology&#8217;s competitors, as well as changes in expected or existing competition&#59; geopolitical changes or other external factors&#59; and unexpected litigation or other disputes. In light of these risks and uncertainties, the events or circumstances referred to in the forward-looking statements may not occur. Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. Results in early-stage clinical studies may not be indicative of full results or results from later stage or larger scale clinical studies and do not ensure regulatory approval. The actual results may vary from the anticipated results, and the variations may be material. You are cautioned not to place undue reliance on any scientific data presented or these forward-looking statements, which are based on Vir Biotechnology&#8217;s available information, expectations and assumptions as of the date of this press release. Other factors that may cause Vir Biotechnology&#8217;s actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in Vir Biotechnology&#8217;s filings with the U.S. Securities and Exchange Commission, including the section titled &#8220;Risk Factors&#8221; contained therein. Except as required by law, Vir Biotechnology assumes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Contacts&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Media</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Corporate Communications, Vir Biotechnology </font></div><div style="text-align:justify"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">corporatecomms&#64;vir.bio</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Investors</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Richard Lepke</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Senior Director, Investor Relations</font></div><div style="text-align:justify"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">rlepke&#64;vir.bio</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>vir-20250509.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:6a9a721f-3de6-4a3c-971f-5dbb294c6c9c,g:d8e09db2-1647-4a04-ba40-d5b7d57fbe81-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vir="http://www.vir.bio/20250509" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.vir.bio/20250509">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vir-20250509_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vir-20250509_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vir-20250509_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.vir.bio/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>vir-20250509_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:6a9a721f-3de6-4a3c-971f-5dbb294c6c9c,g:d8e09db2-1647-4a04-ba40-d5b7d57fbe81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.vir.bio/role/Cover" xlink:type="simple" xlink:href="vir-20250509.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.vir.bio/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_cab41b84-2cbc-4635-955d-c076de7dfbf4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_DocumentInformationTable_cab41b84-2cbc-4635-955d-c076de7dfbf4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_70399ba1-7675-4203-953c-5e319361342f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_cab41b84-2cbc-4635-955d-c076de7dfbf4" xlink:to="loc_dei_EntityListingsExchangeAxis_70399ba1-7675-4203-953c-5e319361342f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_70399ba1-7675-4203-953c-5e319361342f_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_70399ba1-7675-4203-953c-5e319361342f" xlink:to="loc_dei_ExchangeDomain_70399ba1-7675-4203-953c-5e319361342f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_149c7cae-6e06-4d02-bb01-4ed5b11f1d15" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_70399ba1-7675-4203-953c-5e319361342f" xlink:to="loc_dei_ExchangeDomain_149c7cae-6e06-4d02-bb01-4ed5b11f1d15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNAS_eb4a7ec7-4478-4637-9db8-6f25e99bb2b9" xlink:href="https://xbrl.sec.gov/exch/2024/exch-2024.xsd#exch_XNAS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_149c7cae-6e06-4d02-bb01-4ed5b11f1d15" xlink:to="loc_exch_XNAS_eb4a7ec7-4478-4637-9db8-6f25e99bb2b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_25131297-d3bf-436b-9fbd-42d9d516d8ac" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_DocumentType_25131297-d3bf-436b-9fbd-42d9d516d8ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d688d964-7615-4058-8b69-cdcaac2d792d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_DocumentPeriodEndDate_d688d964-7615-4058-8b69-cdcaac2d792d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5c79633a-495a-47d5-9c74-842934c8a2cd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityRegistrantName_5c79633a-495a-47d5-9c74-842934c8a2cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d2aa47a9-76da-4960-aaeb-b3e1dc9f5f2b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d2aa47a9-76da-4960-aaeb-b3e1dc9f5f2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4d6d81db-0adb-4731-815b-5970d62cd2fb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityFileNumber_4d6d81db-0adb-4731-815b-5970d62cd2fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_18b15afe-8d1b-4bbd-a7e9-56c78528c17d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityTaxIdentificationNumber_18b15afe-8d1b-4bbd-a7e9-56c78528c17d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bf335816-604a-43f8-84f5-787300548ef0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityAddressAddressLine1_bf335816-604a-43f8-84f5-787300548ef0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_30519a01-60cc-4f05-96de-67946275b983" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityAddressAddressLine2_30519a01-60cc-4f05-96de-67946275b983" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_38ec1c5e-8357-469d-8e8d-e74d6e318054" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityAddressCityOrTown_38ec1c5e-8357-469d-8e8d-e74d6e318054" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d5ebb24b-821a-438d-9373-572a78aff5be" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityAddressStateOrProvince_d5ebb24b-821a-438d-9373-572a78aff5be" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_fb77eb62-7f99-4c40-a2ac-ebeb7754fb7c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityAddressPostalZipCode_fb77eb62-7f99-4c40-a2ac-ebeb7754fb7c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3f99deec-29db-4e8b-b44d-eda5b03fa5b1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_CityAreaCode_3f99deec-29db-4e8b-b44d-eda5b03fa5b1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6dd56953-dd66-4875-8dc8-0c1164679035" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_LocalPhoneNumber_6dd56953-dd66-4875-8dc8-0c1164679035" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_bc73c167-8fd3-4f08-b730-82df5a09f7f8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_WrittenCommunications_bc73c167-8fd3-4f08-b730-82df5a09f7f8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_450f9faa-81b6-44eb-b935-b5a7d47d79fd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_SolicitingMaterial_450f9faa-81b6-44eb-b935-b5a7d47d79fd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_e9db4af6-56e9-44af-8145-9de8963b20e5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_PreCommencementTenderOffer_e9db4af6-56e9-44af-8145-9de8963b20e5" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_84476955-2275-47c4-b500-a0deebc6c6c2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_84476955-2275-47c4-b500-a0deebc6c6c2" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f1508351-7bb7-4fe2-92f3-0b6711403a5f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_Security12bTitle_f1508351-7bb7-4fe2-92f3-0b6711403a5f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_1e0fa096-5923-4b20-bf39-534037b98c90" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_TradingSymbol_1e0fa096-5923-4b20-bf39-534037b98c90" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_2d447a12-e17c-4991-b70f-69714118a737" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_SecurityExchangeName_2d447a12-e17c-4991-b70f-69714118a737" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5e1547b1-bd72-4365-aae8-2ae79e3f89f0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityEmergingGrowthCompany_5e1547b1-bd72-4365-aae8-2ae79e3f89f0" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_fd52de39-4314-4bb6-97f1-a7d35c34bd8a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_AmendmentFlag_fd52de39-4314-4bb6-97f1-a7d35c34bd8a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_c121e880-3ea9-494a-a509-9d1c3be7d2ec" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityCentralIndexKey_c121e880-3ea9-494a-a509-9d1c3be7d2ec" xlink:type="arc" order="22"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>vir-20250509_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:6a9a721f-3de6-4a3c-971f-5dbb294c6c9c,g:d8e09db2-1647-4a04-ba40-d5b7d57fbe81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_26f085a4-aff7-4dbc-897d-40233cda34db_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_b9a50f61-ee12-41fc-8add-2b7882975356_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_296d0e74-512d-401d-828a-375ac47d165c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_c7750f49-9ae5-4f89-bf6b-60e06f8d8ad1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_8b366b04-f42e-410a-b1c8-03ae29e6fb45_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a95bfd97-8720-4e80-a2ec-054418554d01_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_3dd94fe1-20a6-4af4-a7e3-b5257d328f3b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_d044007a-fa2e-4efa-99a8-aea6583f957a_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_5ae28d5f-627e-4de6-8fd3-2bc176ec501b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_3ac40176-3e96-41e5-afdd-cdef0fcfdf96_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_928066a3-6b8d-4b6b-b342-c8def85cc947_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_241c0245-2b51-4b99-b1e7-1691ebee95a4_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_f7872ccf-4fec-4733-aff3-2b80f436c2b7_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_9fd6cfe2-c83a-4fc8-955a-3e80e8d1568b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c6bdf246-0a48-4fc3-bfb8-57d6962304e3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_f907ed2d-9025-45ec-9ba3-9b35b2fa48bc_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_294444fc-c1cc-4d00-b993-faadab4c9824_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_2bf33b12-5872-4fce-8869-231a31428591_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_2c750d4d-e1d1-45ea-b107-92a1f1f22b9c_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3c8e591a-f8af-4fa5-b7c3-f1d1213ff5f4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_15f09da6-9526-4541-883d-d0a50aa2c811_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_db179709-4d7c-4606-8b90-f1ae3c3392ff_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_33657a5d-4a34-4339-b9a0-d956fa1ee1a4_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_edf2b069-d54d-4229-9645-1eb5169068ec_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_289055b9-94ad-4059-9076-075cddab7132_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_db7665d2-cb75-40ab-b65d-5e4bc12e2fbb_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNAS_9b9f1203-3834-400f-837e-4ba087a1e5ab_terseLabel_en-US" xlink:label="lab_exch_XNAS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NASDAQ - ALL MARKETS</link:label>
    <link:label id="lab_exch_XNAS_label_en-US" xlink:label="lab_exch_XNAS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NASDAQ - ALL MARKETS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNAS" xlink:href="https://xbrl.sec.gov/exch/2024/exch-2024.xsd#exch_XNAS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNAS" xlink:to="lab_exch_XNAS" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0bb917fe-d5f8-4561-9b40-fc7708451860_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>vir-20250509_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:6a9a721f-3de6-4a3c-971f-5dbb294c6c9c,g:d8e09db2-1647-4a04-ba40-d5b7d57fbe81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.vir.bio/role/Cover" xlink:type="simple" xlink:href="vir-20250509.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.vir.bio/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_c9f7189c-2056-43c6-9c72-aaf63c45b9b6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_cab41b84-2cbc-4635-955d-c076de7dfbf4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c9f7189c-2056-43c6-9c72-aaf63c45b9b6" xlink:to="loc_dei_DocumentInformationTable_cab41b84-2cbc-4635-955d-c076de7dfbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_70399ba1-7675-4203-953c-5e319361342f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_cab41b84-2cbc-4635-955d-c076de7dfbf4" xlink:to="loc_dei_EntityListingsExchangeAxis_70399ba1-7675-4203-953c-5e319361342f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_149c7cae-6e06-4d02-bb01-4ed5b11f1d15" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_70399ba1-7675-4203-953c-5e319361342f" xlink:to="loc_dei_ExchangeDomain_149c7cae-6e06-4d02-bb01-4ed5b11f1d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNAS_eb4a7ec7-4478-4637-9db8-6f25e99bb2b9" xlink:href="https://xbrl.sec.gov/exch/2024/exch-2024.xsd#exch_XNAS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_149c7cae-6e06-4d02-bb01-4ed5b11f1d15" xlink:to="loc_exch_XNAS_eb4a7ec7-4478-4637-9db8-6f25e99bb2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_cab41b84-2cbc-4635-955d-c076de7dfbf4" xlink:to="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_25131297-d3bf-436b-9fbd-42d9d516d8ac" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_DocumentType_25131297-d3bf-436b-9fbd-42d9d516d8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d688d964-7615-4058-8b69-cdcaac2d792d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_DocumentPeriodEndDate_d688d964-7615-4058-8b69-cdcaac2d792d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5c79633a-495a-47d5-9c74-842934c8a2cd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityRegistrantName_5c79633a-495a-47d5-9c74-842934c8a2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d2aa47a9-76da-4960-aaeb-b3e1dc9f5f2b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d2aa47a9-76da-4960-aaeb-b3e1dc9f5f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4d6d81db-0adb-4731-815b-5970d62cd2fb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityFileNumber_4d6d81db-0adb-4731-815b-5970d62cd2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_18b15afe-8d1b-4bbd-a7e9-56c78528c17d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityTaxIdentificationNumber_18b15afe-8d1b-4bbd-a7e9-56c78528c17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bf335816-604a-43f8-84f5-787300548ef0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityAddressAddressLine1_bf335816-604a-43f8-84f5-787300548ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_30519a01-60cc-4f05-96de-67946275b983" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityAddressAddressLine2_30519a01-60cc-4f05-96de-67946275b983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_38ec1c5e-8357-469d-8e8d-e74d6e318054" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityAddressCityOrTown_38ec1c5e-8357-469d-8e8d-e74d6e318054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d5ebb24b-821a-438d-9373-572a78aff5be" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityAddressStateOrProvince_d5ebb24b-821a-438d-9373-572a78aff5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_fb77eb62-7f99-4c40-a2ac-ebeb7754fb7c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityAddressPostalZipCode_fb77eb62-7f99-4c40-a2ac-ebeb7754fb7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_3f99deec-29db-4e8b-b44d-eda5b03fa5b1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_CityAreaCode_3f99deec-29db-4e8b-b44d-eda5b03fa5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6dd56953-dd66-4875-8dc8-0c1164679035" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_LocalPhoneNumber_6dd56953-dd66-4875-8dc8-0c1164679035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_bc73c167-8fd3-4f08-b730-82df5a09f7f8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_WrittenCommunications_bc73c167-8fd3-4f08-b730-82df5a09f7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_450f9faa-81b6-44eb-b935-b5a7d47d79fd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_SolicitingMaterial_450f9faa-81b6-44eb-b935-b5a7d47d79fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_e9db4af6-56e9-44af-8145-9de8963b20e5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_PreCommencementTenderOffer_e9db4af6-56e9-44af-8145-9de8963b20e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_84476955-2275-47c4-b500-a0deebc6c6c2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_84476955-2275-47c4-b500-a0deebc6c6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f1508351-7bb7-4fe2-92f3-0b6711403a5f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_Security12bTitle_f1508351-7bb7-4fe2-92f3-0b6711403a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_1e0fa096-5923-4b20-bf39-534037b98c90" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_TradingSymbol_1e0fa096-5923-4b20-bf39-534037b98c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_2d447a12-e17c-4991-b70f-69714118a737" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_SecurityExchangeName_2d447a12-e17c-4991-b70f-69714118a737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5e1547b1-bd72-4365-aae8-2ae79e3f89f0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityEmergingGrowthCompany_5e1547b1-bd72-4365-aae8-2ae79e3f89f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_fd52de39-4314-4bb6-97f1-a7d35c34bd8a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_AmendmentFlag_fd52de39-4314-4bb6-97f1-a7d35c34bd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_c121e880-3ea9-494a-a509-9d1c3be7d2ec" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_c72c8db5-62d4-459a-bad6-effdb1e29bbc" xlink:to="loc_dei_EntityCentralIndexKey_c121e880-3ea9-494a-a509-9d1c3be7d2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>imagea.jpg
<TEXT>
begin 644 imagea.jpg
MB5!.1PT*&@H    -24A$4@   <8   !J" 8    FR_$(     7-21T( KLX<
MZ0    1G04U!  "QCPO\804    )<$A9<P  %Q$  !<1 <HF\S\  !QI241!
M5'A>[9T-L"5%=<?;2!(TFI"$*%8@HD9+HU$C6'YB2 )(&2LQ)2A5L;)$";++
MN]U]>MZR6R3Z-/A1A@!14(P85UD33-:XHB1^@#Z5*(DH[]X'"H; JJB4HA""
MD>CJW-3IF;D[<Z;GZ][[WKOO[O]7=0KVS>F>GIZY_9_^.J,4
M
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M]WB9-H\F>Z5,)TT[NEZF P   &:*IAYC3M2^J(E>(--G&*(;91IIVM$],AT
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M\X-S@[QI/^ZK/5( *PUSC    &8!8\Q3)QE:_?S>QP=[>O% 75 2OQI#CQ$
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M..<>9XB^5DY?+W;^@\SL1_:S9RXM/5@>S[,9A+%)0/*$YF^2/,(+5#):"V/
MKZE'EA%:)5LWIR=]VP@C-\B%-).)=E%D0HN#<JN3QV%<8=RVM.TAQM%_%].6
MAT@G$<;T=R0;\9(8I?52\&N[K#\5&7F.DE"T%49>/"+]VBSN8=*RC+Y36U66
M=!YNW.MM)8R,MGZKF;@6V[@JU#CW4CZ'MO8CW/.7Q^<&_J)%/%!GQ'WE/R:\
M5N;S7U6-@M7K]8YLNVJNQGCI?6/OT3C[SG+:XA<R)(;(AX#3SO+#6LN\"6.&
M_P&*7F2=L(0$+R2,P3GG%CW2#)FV3KA*OC7E9](A49&F_H4@0SX'86'D+0WB
MVL<,/)$QKC RQM&7"F4F^VTY73&),%IKGQA(>Z5,FR[T*C;V%8N!0L@%*5SW
MLO%O*XQRKI"MS3!J1BE6LZ.54EG$W&*7<W011EJDDWO6_"#ORT/$M+T^=G3/
MVMV^M^@<A^\LY3L7I!OT/R1%;-H6]]6>>$4]1YZ_CF0XQUXA;EPWJ^DQ,,:9
ME\HTFN@6K?6O25_&[[]Q]$7CZ/^LM<'YD#RR04QL\PLC(^<"T[H+"E%K80P,
MV4J?.KI<FSQ/HS &>G2A:P@12BN']$)S;ENW;CTJ[].5B80QL,)1#AM/(HQR
M[M6G#0R1RE6=;++NZI!#GVP[=^Z4U]%6&$MED7G541HB#0RGRKE(-FYW\CY5
M=!%&1I-YK[QN[>R;J_RYS>N1Y;"=@RB*'BF/;WKB&]6SXX%Z^UK,(^:-]SO&
M W5^O*(J5VXVD<X_[AYW@0XO19=Y9F2Q3DMIB%XA?9DL!)PF&@5#KV.>A9$)
M]O "0Y_C"F.36$GD4*>WBH4[TJ_I7'*+2F+E>QDB)(SR_AI'<K]B'%H)VH4Y
M$<:2L'44QM*>1[EPIZTPAD1+]OCJT-:6KD6*GAQN99/B64578:1%>K'T-XZ^
M%NV,CI&^C(G\:!D/H_*'%X)Y;DK\L&E?+<9]=9\4L6E;/%#W\%8/689QX6T9
MO#*NVX9G/P2TGR.'R/PRTL@?,LW[I!]S( 1<?4\T8]Z%,21XH5YCR$\*8]K(
M%O-*&LK6R(4[WBJVDDB_)F$,W<ML 5*3R3E&;[EGB!<T\"A$,6_[/Y,V/O,A
MC.5KZ")&<M&+/X]8G=I&&$/SE?S,="Q+:9B4<I^]X_J<Y!Q=A3'Y@+OEEUMQ
M#^WK9)K>XN)C-%D>7O^N.Z?=MK9-@?\DU$!=)05L+2P>J+^+^^H9L@S3((T(
M<EJP$:RR&I&QD?W=P%O:=^UV^[2\7_I@W*X=?:M.:/.$&M,Y$\923R@D,"V%
ML;1X9@QA;-6#9:1?J-QY@N(VB8F7JT#CM%\V3ET)B4K;/&=!&"M\2G.$=02%
MD31_^W4FA#&_#2.T0"<TW%I%5V%D#-&?R#2\9<CM=(_+^V6+@K2S[^ERS3/+
M<)\ZE,.X2?%:"^->XG!%E1K^M8(%JM5"G0:1T40?+:4AVI'W.1 "CB[/_[V.
MN1?&<"^OE%]+80PL;JD7*TGP9:EB\8[T:SI7\%[R\"K7P7@V&N)-0V3);30_
MVK)ERZ'%4G1CLPNC]PM<0Y=YO=!0JEQ)VD88F8" =!7IDC#*A37K+8S;MV]_
M*$>^R:=)TAEN_WPZWL*FR5S-97?;_8*PROPV!<,5]=2XKVZ6 K86%@_4A^.!
M.E*683WP"W7*>\ .6(/(:**HE(;L-?D',@L!QV]8Q=35!!O3^1+&4B^/K>37
M0AB9P!QCI[)U22_+TR2,H6N0O;Y)" D YAB]F)3FY3H*8VG!C!2C#L)8JI,N
MPAA*+T5/KEP-^50QCC R-HK.DM>O'7W.GFM]#%0;1:?X?,E><\$%%S3M\YYM
MXA6U,&ZP[R[&\5/COEJ3\&5=Z/5Z/VN(M(P<DEAX."U#+^HG\W+T0+KG\W$?
M1HD%A>R7ZD+ 20X"82RO3 T(3$A4@L(8Z/%)GSH"PE@Y%"O/$RIWGM"P\32%
MD>>U9?X]:T^2?EV8$V$LA8^3BV?JD,(:ZN6U%<;0=HTN(BT7[X2V:X06Z#CG
M6EWON,*8?M"AM*>;(O)#SOPAX>2Z7>=@XS-#W%</XY6@4L"F;JOJ"_% V>$M
MZG!9AHV$]T'R)VX*-[F%R(3FI[)]:CUG%]._72K3U3'WPAA8J3GNXALF.(]7
M,10J"0[%$NV2?ADEWP9A9$IU%[C6<0G5Y:3".Q_"6(Q>DYS#SQ&V0M9!\!PM
MA5'&:V7K(%KE^<- 1)O@G&A%*#O)N,+(A (+<%UQ[UJ3_2$_^[U>[^=ENDU!
MNEE_;TG$IF@<&2<>J#=RI!QY_EG!KV!U=.F!FUS?8V3XBP;YAR)Y<.U=?K%/
MN@V O^DGT]4Q[\(8>ID(U75;84P;VF)^+<5!"HN_SHHZS#Y[(_R;A;$<W+RT
M47]<S*+_S-CG"_F3Y0WO8R-%@:UM>6=&&!._HK@E+SS-YPA$S9$+;[Q?2V$,
M+< )^84(E26_(G7D%Q+0EO.,DP@C!W</#>-F;9^_S@[#QC-#NA5CCQ2R:9D7
MQ%6U*_ZB&OMS3^M).CR0S M6-)!Y_(-1CA_H&_#D ;&WRC1-S+,PAH86_8\H
ML&^PK3 RLM?8MGQR&+8I*HU<<*7)?EWZ2(+"';B?XQ)Z.>L1/5/ZM44*"EN;
M1I*9%6'TOD)40L.A(>3"FZJXIFV%D9$]JPYE*2R\J<J?"?5,IQE$O K^B((\
M;VKWFBA:D_9HS6'1DF(V#>,]C_&JNFAXD^K\>:>-QHLC?S&\I<B$PG)E*UZK
M&O(ZYE48N6RA?*KW#+871O_&7(J 4ZZS/#)_GSX@T'F*(PJC.J]-PX2$6PK&
M)(Q>YHK7$JS7)N9%&!DY5U@G+$RZ,*SP%8RJN<DNPLB4Y@H#O= \:?Z%LC3-
M39;.X6A?T[#MI,*HM7ZR(?N?^?3)]=E_:"/^,T?<5UOC@?JQ%+5)+.ZK?MQ7
MKX[[JM6>O5G%QUYMN>]0$[U /A3)0VE_H)WK-(S*S(LP^D;,-V3F]&QHI9!'
M\DW&RKE *5QL5<+(^!]X2W%,RS2ZIJ1\Y>%<"??$RMM\[!4\<B!]):'[U=1#
M;0M/ Y1ZOV-^DW&NA)'/)<I4%5P[)(IUXM55&-/\6XEC2!1;]OXX7>G^\7QC
M*/)/\ILI]S2["".31;?)YV&=^^,N><P,\4#MD\(VKL5]=4>\HBSO?Y3GF7?X
M$S_:V4_)AY&W@DC?-FP&863C!JG"2M]B+*3C!CS9RU?;T^HJC!F!WMD^7U<'
MO@;/93P@BGRLH2QY@O?'1U;BQ5MV=W9],AV3"G(IMFM:QKW>N(Q^GRTM%^JS
MQ;W5SKW0D+VYD#='<4KR7T[SW9654SNZ7I8UU+"V;>"D"+%MI#!F!(8R1\\$
MW\_ ,[$<$I(\784Q0PI1T_/)(B7KL(G02MA\?>7/$7H>.PNC,<_29+\Y.@?9
M3^_8L>,7I-^F(.ZKKTN!ZVIQ7UT=#]2VS3AD.DV2ASKY!F%F(3%K0YK7/7D+
MY;7.PN@;YPZ6_/B2QGY7(E;F]"[#>]R#D_FV$48F&1YBD0D+M,^/%P&-65]I
MH\B;E^^3>1NB&SG*DDR3)[DV+X L3J6&291SV==?3>\Z3QKEZ66&Z+*TC'?(
M?)-RVCO]E('H*1OG/B.?Y;:-9)NTR0IPXFA0N=^*O4+ZA9@D;=([\L)3]TPL
MAWYK(7CT0):ERTI0%J^&LNQMTTNL(NL-RF?LP._37<3#Q),.I6:8B"[)Q%A;
M>T[7]#/#)#W&>*"N'ZZHQJ$G #::-&+,4[V8)?\M1)"9%!ZJG$:>N7+ZO";-
M+X^?-T_R/9J'7>7Q@XVU?B:ZL)YE">5;(8R-/5]).LW ^=PG@YQO*N*^6I6"
MUV1Q7WTZ'J@_B[^N-G<D P   %,31NO<J[C'J&WU)Z@V!?% 72N%K\I\/-.^
MVGDPSB$" ,"\XE>+RWBN%8N"JEA<7#RB1Y;WT][OG#M1'M]4Q'WU&2F (8O[
M:G<\4(T?V 4  +"YL)'=(A?J6&L?+?WJL,Z=88CSL._?E%LT\L0#M2Q%4 CB
M?>OYU0L   #KRX&8IJ/%.:58K$WTK+W2Y['H6"\ZI9TYXH'ZD!3#D2@.U"?B
M5?4"F08  ,!\(+>QL(5"SM5AH^CW.1P=?UG#+;F9BH$]%E51;W@+QO +LQ7D
M&P  P'1(MXMPX/%1$ '?6VRYW22/=N[M+*X]9_Z\:]J9)!ZHRP.B^-:-^CXB
M  " \4E7F-[M]U0F 1U&^XCS02/R8I@LMF'?[GLF=10=HYW]!L<,IAT[GB*/
M;TIDCY%CFTH?    FX,D,I#[0$C\<G.(HR <'!ZO*A9L&PS1*SG(P3C;.V:6
M>*#>DIM3O#B^64WTY6\   "S0QHHP@=V2(,'E#;X \%P1;TF%<5E_OR4/ X
M   <5+ PIELR6L5@!    .8:+XPK:D'^'0   #@H&:ZHL;XL
M
M                          " M>/_ ;'2%SR1&AIB     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 09, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  09,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Vir Biotechnology, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-2730369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1800 Owens Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Francisco<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">906-4324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VIR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001706431<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNAS', window );">NASDAQ - ALL MARKETS</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNAS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNAS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( /I"J5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( /I"J5H3$NF/[@   "L"   1
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
M-5"I0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K
M!LIDR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1U
MW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@
M;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ ^D*I6F60>9(9
M 0  SP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL
M6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4
M'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I
M>.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY
M'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?K
MT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;
M@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"
M% ,4    " #Z0JE:1L=-2)4   #-    $               @ $     9&]C
M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( /I"J5H3$NF/[@   "L"   1
M          "  <,   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( /I"
MJ5J97)PC$ 8  )PG   3              "  > !  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ ^D*I6L%)&N"(!   A!(  !@
M ("!(0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( /I"
MJ5J?H!OPL0(  .(,   -              "  =\,  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ ^D*I6I>*NQS     $P(   L              ( !NP\
M %]R96QS+RYR96QS4$L! A0#%     @ ^D*I6JK$(A8S 0  (@(   \
M         ( !I!   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( /I"J5HD
M'INBK0   /@!   :              "  002  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( /I"J5IED'F2&0$  ,\#   3
M      "  >D2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
' #,4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="vir-20250509.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.vir.bio/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="vir-20250509.htm">vir-20250509.htm</File>
    <File>vir-20250509.xsd</File>
    <File>vir-20250509_def.xml</File>
    <File>vir-20250509_lab.xml</File>
    <File>vir-20250509_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "vir-20250509.htm": {
   "nsprefix": "vir",
   "nsuri": "http://www.vir.bio/20250509",
   "dts": {
    "inline": {
     "local": [
      "vir-20250509.htm"
     ]
    },
    "schema": {
     "local": [
      "vir-20250509.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "vir-20250509_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "vir-20250509_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vir-20250509_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://www.vir.bio/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vir-20250509.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "vir-20250509.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Listings, Exchange [Axis]",
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange [Domain]",
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "exch_XNAS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2024",
     "localname": "XNAS",
     "presentation": [
      "http://www.vir.bio/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NASDAQ - ALL MARKETS",
        "label": "NASDAQ - ALL MARKETS [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001628280-25-024067-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-25-024067-xbrl.zip
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ML-/]5:G/XKUQOONR2(49B4\$8(;RB?12C(P5G\Q03?506B\D;GJ9J:'35A;
M<S[$2%Z;P@F-SQ-K"IV(UZK$1:^=>"%&UN3"3Y1X>_3A^+7XZ*MTMGBL5QUH
MN'=HGZ]]K)1I"G7K9FH$$>ST"&C+0X5+NDBQN8-NN.T;'<O.RF-Y]'!_T.\?
MUMNXT8EYG /ML>/DRJ4<+@ALO[?UE"3Q^H4[&HO,. =@B', PXF2D*$",GR#
M#)E,M)K"RN',^WN_,"H&_5_HIE*2RNA2%MZ)<^TG&/!<#*53M @1YK J47I*
M!M+/H?5_0C7 H@=-Y07 QV.\?_FW[NFKLT</G^[L'G;PO"M5XO5493/Q$TQW
M$4Q'P([%T9K*X8QD-#]I1[R?  MB6Z0 4&9*QA-@E$33,6F9#F^$29+*"E-@
M# :"%./,#&6V\#C!+S%YKFR"W>G_LD%B)!;*=L3Y1"<3@6E%8;P8*E4(IS"L
M2G]"YRY"9]E[ 0B.K$_.-H2<R0AN)\-%.'1'9B<XEX"M :[#R=!3JG X9X"C
M\+JH8+!:Y@E(*-1(!_@X.5)^QEC)E)!EF<W(/,T?I D+@A<&5^?2IFZB2_'3
M^-Q)!'T"0L!-<,HS^ H-^@5.[D0BW438JCB7,S&N=(H#5; ]P$FNTRXH^5Z'
M/16\7<$H@Y&P9&!,22,0(,I,%C_/_.Z?>2XU*"DY!>TI',,9:Q"292^3J@PL
MM[1F;&5^X?@]J(@# <[9H4#U2Q@E& 3\C^C0:NJ"F2(]HNG+3'FU--T4=\*0
M5"5<I'/DK. !I<CE;\9J/PL\RFO,Y6X:;#?]V/<):#X>G8E7'X[.CD\_'K_K
MB+=0X*<=#J*_"1POU0,1%4$L^:F.."V2GM@XDRZ5OS]ZN+N/FTX_; (3J6R1
M((J[B%ZO8=<IQUT4-KTG<+W@;P%'4XP-V:!%7Y=@A12C1J>GIC*K@JWRBV';
M>G9=JO$LXZR%IE!UI* D"*'+B10;"\Q[DW"ZS/!7<;>-X]<O-GN"M)(7UDWA
M:PORP!9A.&)/;+O$=GR'E*\TECG;R@"B@LV#D+T<9FIA#OCVD80)QZUZ#%:W
MP='%II#^B@ &?AYLL(EBAC..8C:V'SW<V3OL[V\V 4U]:6=S]=(6XYI'#Y]L
M'?8[ )TX_0<_F+]9'>M<?AZ71#M!HI"'!$]) U3.%2@.61)*-*0UV#QCYF4%
MX2K,<>2< 7UA*5-,3U]R+%ZCZPW&MV+CY=''-YO$>\9DFNB\CW(P'IO*7&S0
MW&<*=UNXP=1M]NZMF5FMVL"L +(D8E9R+]*1'G4@A%$F<W@! ]QF+*=4.T7Z
ME\C*!021#-O@A(VO'$'RGW,QW<!.]GK]W6OLY1"XUW38!U9!M;'F0V_*@^YV
M;W]%8JN&\8/G_5NPIX2J7XW-4O%:R0SX?V?'LJC#.(5#R)F^^0DI]NX.V%J6
M<82G#/PKGTA0')Q?AW5+SI]+1;_7;QZ9*6D12Z8P!!,<-!1'1L7 C3P&G6,\
MW7MT;H-;.#=B6^!K,?W'#HL4*(?UT4625:F*RI)H:R?8E^O$"R-8+XK+Z*CB
M+<3%[3T2^/8M"/PH(S\Q9IR3Q!#!!I]&>16RRHJL5PQ:@/+"T(?[!./^#^90
MWK<9@ZZC"@H@ BU@=_TUK*#73LHSF4ES\$#RU!@3=G(;)"0?@PXJ^*Q(AL!(
MGQ[.9^@P45I['ZWF A,AXE ')BUBHST/U=_? C?N[_</QSP.L97W2Y2IE67>
M@%1-DL$DD_:#=8VP?+&S'ZG; BD^GR!*5QZKUV,]U!F%28FET%Y+LM?S3,W0
M8):S#Y].Q491873C-ORFAC&RM$D7PSH\6WKRX+K@<I.QF!]+5%E&_W[=J<S7
M&WA:G3^0"!YGL'^U770MCE^NA0AM>2*GM'!05>R,:S5@MBLY;0@W=ON+ _X!
M]KFX$[IG>W#=YR^"\PCQ V+T&#;W][]J41=79%7+MLET2ODX&@/1!QG%1G"]
M]5FY=O%SV42M*X?&BN#6_!$Y=":K_/(C:VU2^^^)G:=^QJH[Q!%^[C+X#V1V
M+F?NP4U6;=<NYAY9US59@=6!Y6@$WY+,(TSQ+3-75U/;->'OTBJUNS(2#K9S
MP6J*C7ID6*V%2/FZP7#O8GWWNL8. 6*5A:R!N'[M,)8,OTFPO2)6=JHE51=B
MY7W,M<./[/;#]/TGN+3+E[8'FR% OH%HO<-Y/7B4]F;N;]"\6@M?5442#3VQ
MS5O4MHLKX7QKHQP.LI'\85E-^(@1JHN3LR.P:BI9DSO!OR DU"[A"9*_5Y1I
M&L601VQL];9VY^"[AJI%AC.G*^2_B*JX&U'"T<7]0]5(KP8+JM;?G5_:7J-J
M+0W[&@7;:69H%&RKT>_MK<TF Y6T&TC^M&+=>#7NEC7KK4F!-BH^7CC8#6S=
MG!-X0B5AF.G2;=ZBYH'OJ2\EI@@YLGS-PCNB63B3< HD: LJ!XG?6-A+2W%)
M+S] +X&+H*P*BIC11SDT4W4-326X03C[6SN'V[O@WC,7,\"9,W7&7*4WHH-7
M&(!UDA&A0HE[5VCL8'ON'+?7Y.#_I,8^:69H-':[\9(_-?:ZBL!\CUL)6(;>
M9,K*&*U"YB-J+E@L'2[B3(9F!4>!/ 6]7)VQVEAFD5JYF/^GZ-%-V$O%1'_K
M7,CO<1P;IN?L$(]4&%&H\WJ!F"=1%J=(2QBK K=F"*RXUP8"2>E4 5<>H85@
ME2L[9E^6AG :436A<*A(K:TB7%%:(T1EA Y?D^ ?[K@?/=S>.?S4]#;RL:0J
MQP'Z(#4ZG06-N>SP*:-7EX[I&ZIA$V-IDVNN$[MJZ)2_=K==1JU2KD/>8= _
MQ/'K5+R5]K-XJ1TW2+T]Z>&O]Z\[XABSC\1;E7)%\1W%*'3#4J6SQ[YFL'48
MS E,-17D.8"94JI%YP0#R73?D<!<Z+-@I$Z ,U7$QIVP88+."O:RJK!(DCG7
M0+<NJ#2/QSS=W>X'0VR%V9ML"NQMEO;J[?]@$%SLLZ.&AXK*P7Y=JQU$?FU
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MJ'22 \HV!F+&F3&@/A)<L)/<P'"<7/-3ZZS?.2ZLK?",!3L!X#=OPXJ2^MV
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M:X):N:M5#K]9>FY/SK,0-, E<N9Z[&H7055;%:-4=$I;9VM?6QZW5BZ?P$F
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MIUB==>^2B24(>FUK.82ZX'+$T?TA3]U+\=S+,:J+RS%&<NDC#;GA2DYO##H
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ML6_"M=,1?I$#:E",$S[T0#),TE)$UXYK)Q]'KTE4GJR(70*5PJT>(U72@J)
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MPT[M>Q112/XQ'_T/ #7_"U!+ P04    " #Z0JE:MJR$47("  !;"   $
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MZK2K=%_H5)LQ2024:0QPB(P%AP)D**,@2C'E<2K"!/.NPK0!'%F2*\BG^]&
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M_8WWVX2PV=$+??7AU>J5?/'?Y'QX]7]02P,$%     @ ^D*I6@W+<$[=!P
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MU=H594X%WB#! 5&0X1T3,T:\SR@1@.LGI8E&*L>A<<_>YG"8:O:J2:3<( 2
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M,(;*^+A']#];'$;"?$JMHQ3=, U_U47;0KE?K=?GY6V6WN0^:!ZHTL2DR+N
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M"   $               @ '-)   =FER+3(P,C4P-3 Y+GAS9%!+ 0(4 Q0
M   ( /I"J5K=F!II'P@  ,8[   4              "  6TG  !V:7(M,C R
M-3 U,#E?9&5F+GAM;%!+ 0(4 Q0    ( /I"J5JF8S47& P  /9H   4
M          "  ;XO  !V:7(M,C R-3 U,#E?;&%B+GAM;%!+ 0(4 Q0    (
M /I"J5H-RW!.W0<  )4^   4              "  0@\  !V:7(M,C R-3 U
@,#E?<')E+GAM;%!+!08     !@ & (\!   71      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>vir-20250509_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:exch="http://xbrl.sec.gov/exch/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vir-20250509.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001706431</identifier>
        </entity>
        <period>
            <startDate>2025-05-09</startDate>
            <endDate>2025-05-09</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001706431</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNAS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-09</startDate>
            <endDate>2025-05-09</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-23">0001706431</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-05-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Vir Biotechnology, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-39083</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">81-2730369</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">1800 Owens Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 900</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">94158</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">906-4324</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">VIR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
